EL7.AI
Mergers & AcquisitionsMedium•23 September 2026•
2 min read

Aurora Cannabis Files Regulatory Challenge Against Curaleaf Hostile Bid

Key Facts

1Aurora Cannabis filed an application with the Alberta Securities Commission alleging deficiencies in Curaleaf's hostile bid disclosure circular.
2Aurora claims Curaleaf failed to provide pro-forma financials and did not keep the bid open for the required minimum regulatory period.

In a move reflecting the intensifying legal conflict within the cannabis sector, Aurora Cannabis has filed a formal application with the Alberta Securities Commission to challenge Curaleaf's hostile takeover bid. The company alleges significant deficiencies in the bid's disclosure circular, specifically citing a failure to provide required pro-forma financial statements. Furthermore, Aurora claims that Curaleaf violated regulatory standards by failing to maintain the minimum required deposit period, potentially undermining the transparency of the acquisition process.

This legal escalation occurs amid mixed market sentiment for both entities, with Aurora Cannabis (ACB) shares closing at $4.27 per market data on September 22, 2026, after trading between a low of $4.03 and a high of $4.29. Meanwhile, Curaleaf Holdings (CURLF) ended the same session at $11.62, having fluctuated between $10.46 and $11.63. These price levels highlight the market's cautious stance as investors weigh the potential for regulatory intervention to stall or block the deal.

Traders should closely monitor the upcoming decision from the Alberta Securities Commission, as a ruling in favor of Aurora could force a revision of the bid terms or extend the timeline significantly. Based on the snapshot at close on September 22, 2026, the recent daily highs of $4.29 for ACB and $11.63 for CURLF serve as immediate resistance levels, while the daily lows of $4.03 and $10.46 may act as support if legal uncertainty triggers further volatility.